Welcome to LookChem.com Sign In|Join Free

CAS

  • or

15963-40-3

Post Buying Request

15963-40-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

15963-40-3 Usage

Description

Cyclobutanecarboxylic acid, 3-methylene-, methyl ester (6CI,8CI,9CI), also known as 3-Methylene-cyclobutanecarboxylic acid methyl ester, is a colorless liquid chemical compound with the molecular formula C8H12O2. It possesses a fruity odor and is commonly used in various industries due to its unique properties.

Uses

Used in Fragrance Industry:
Cyclobutanecarboxylic acid, 3-methylene-, methyl ester (6CI,8CI,9CI) is used as a fragrance ingredient for its fruity scent, contributing to the production of perfumes and scented products.
Used in Pharmaceutical Industry:
In the pharmaceutical sector, Cyclobutanecarboxylic acid, 3-methylene-, methyl ester (6CI,8CI,9CI) is utilized in the manufacturing process of various medications, playing a crucial role in the development of new drugs.
Used in Food Industry:
As a flavoring agent, Cyclobutanecarboxylic acid, 3-methylene-, methyl ester (6CI,8CI,9CI) enhances the taste of food products, providing a fruity flavor profile to various consumables.
Safety Precautions:
It is essential to handle Cyclobutanecarboxylic acid, 3-methylene-, methyl ester (6CI,8CI,9CI) with care, as it can be harmful if ingested, inhaled, or comes in contact with the skin or eyes. Proper safety measures should be taken to minimize potential risks during its use in various applications.

Check Digit Verification of cas no

The CAS Registry Mumber 15963-40-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,5,9,6 and 3 respectively; the second part has 2 digits, 4 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 15963-40:
(7*1)+(6*5)+(5*9)+(4*6)+(3*3)+(2*4)+(1*0)=123
123 % 10 = 3
So 15963-40-3 is a valid CAS Registry Number.

15963-40-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name methyl 3-methylidenecyclobutane-1-carboxylate

1.2 Other means of identification

Product number -
Other names 1-Carbomethoxy-3-methylencyclobutan

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:15963-40-3 SDS

15963-40-3Relevant articles and documents

-

Ooba,S. et al.

, p. 144 - 146 (1967)

-

Process for preparing 3 - methylene cyclobutyl derivative

-

Paragraph 0019-0021, (2021/10/13)

The invention provides a preparation method of 3 - methylene cyclobutyl derivatives, and uses propylene derivatives. Through screening of technological conditions such as polymerization inhibitor, reaction solvent and the like, the problem that propylene derivative polymerization blocks the reaction channel is solved while the product conversion rate is ensured.

1,3 DI-SUBSTITUTED CYCLOBUTANE OR AZETIDINE DERIVATIVES AS HEMATOPOIETIC PROSTAGLANDIN D SYNTHASE INHIBITORS

-

, (2018/04/27)

A compound of formula (I), wherein R, R1, R2, R3, Y, Y1, a, X, and Z are as defined herein. The compounds of the present invention are inhibitors of hematopoietic prostaglandin D synthase (H-PGDS) and can be useful in the treatment of Duchenne Muscular Dystrophy. Accordingly, the invention is further directed to pharmaceutical compositions comprising a compound of the invention. The invention is still further directed to methods of inhibiting H-PGDS activity and treatment of disorders associated therewith using a compound of the invention or a pharmaceutical composition comprising a compound of the invention.

ISOXAZOLE DERIVATIVES FOR USE IN THE TREATMENT OF PULMONARY DISEASES AND DISORDERS

-

, (2017/03/21)

The present disclosure features disclosed method of treating disorders such as COPD, bronchitis and/or asthma using disclosed compounds, optionally together with one or more additional active agents. Contemplated methods include administrating orally or by inhalation to a patient one or more disclosed compounds.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 15963-40-3